Zions Bancorporation, National Association’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$450K Buy
10,537
+7,173
+213% +$389K 0.03% 266
2026
Q1
$211K Sell
3,364
-3,877
-54% -$310K 0.01% 339
2025
Q4
$690K Buy
7,241
+5,497
+315% +$539K 0.03% 284
2025
Q3
$170K Sell
1,744
-1,328
-43% -$138K 0.01% 392
2025
Q2
$330K Sell
3,072
-1,714
-36% -$173K 0.02% 300
2025
Q1
$483K Buy
+4,786
New +$482K 0.03% 268

Other funds holding BSX

Zions Bancorporation, National Association's BSX Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its Boston Scientific (BSX) stake by 213% in Q2 2026, buying an estimated $389K and bringing the position to 10,537 shares worth $450K. The position accounts for 0.03% of the portfolio, ranked #266.

Zions Bancorporation, National Association first reported a position in BSX in Q1 2025 and has held it in 6 quarters since. The position peaked at $690K in Q4 2025. 534 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Zions Bancorporation, National Association held 10,537 shares of Boston Scientific worth $450K as of Q2 2026.
  • Zions Bancorporation, National Association bought 7,173 Boston Scientific shares in Q2 2026, an estimated $389K.
  • Boston Scientific made up 0.03% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #266 holding.
  • Zions Bancorporation, National Association first reported a position in Boston Scientific in Q1 2025 and has held it in 6 quarters since.
  • Zions Bancorporation, National Association's Boston Scientific position peaked at $690K in Q4 2025.
  • 534 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.